Jump to content
interreg EU logo 404px
 

CWPharma

Residues of active pharmaceutical ingredients contaminate the water and marine life of the Baltic Sea. In CWPharma, partners from seven countries work on tools and recommendations for policy makers, authorities and municipalities to reduce these harmful emissions.

News, press releases and events

Campaigning in Germany.jpg
Actions needed to reduce pharmaceutical emissions in the Baltic Sea region 2021-06-21
Since 2017 CWPharma project has worked to gather data on the consumption of pharmaceuticals and their concentrations in the environment, to identify the most problematic compounds and to find the best ways to decrease their emissions to the environment. One of the key findings is that twelve out of 75 studied pharmaceuticals were identified as a risk to the environment. The Action Plan for reducing emissions highlights the need for combination of emission reduction schemes.
Read more
Stakeholder discussions continue in Finland 2021-06-11
Experts from the Finnish Environment Institute and the Finnish Medicines Agency Fimea discussed the CWPharma findings and action plan in June 2021.
Read more
CWPharma Final Seminar presentations now available 2020-11-19
The CWPharma project´s final seminar on the 18th of November 2020 attracted 131 attendees from over 15 countries. The seminar presentations are now available.
Read more
All news

Get to know our work

wp2 83px

Work package (WP2)

Emissions, levels and risks

 

wp3 83px

Work package (WP3)

Advanced wastewater treatment

 

wp4 83px

Work package (WP4)

Low-tech risk reduction

 

wp5 83px

Work package (WP5)

Conclusions and Action Plan

 

wp1 83px

Work package (WP1)

Project management

  • Print page